Connor, Clark & Lunn Investment Management Ltd. Concert Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$4.34 - $5.84 $42,371 - $57,015	-9,763 Reduced 3.25%	290,595 $1.7 Million
Q2 2022 Aug 05, 2022	SELL	$2.8 - $6.36 $93,520 - $212,424	-33,400 Reduced 10.01%	300,358 $1.27 Million
Q1 2022 May 12, 2022	SELL	$2.73 - $3.94 $3,513 - $5,070	-1,287 Reduced 0.38%	333,758 $1.13 Million
Q4 2021 Feb 10, 2022	SELL	$2.69 - $4.22 $12,890 - $20,222	-4,792 Reduced 1.41%	335,045 $1.06 Million
Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $4,774 - $6,249	-1,506 Reduced 0.44%	339,837 $1.11 Million
Q1 2021 May 13, 2021	SELL	$4.86 - $13.07 $544 - $1,463	-112 Reduced 0.03%	341,343 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $24,610 - $33,332	-2,596 Reduced 0.75%	341,455 $4.32 Million
Q3 2020 Nov 12, 2020	SELL	$8.67 - $10.82 $69,091 - $86,224	-7,969 Reduced 2.26%	344,051 $3.38 Million
Q2 2020 Aug 13, 2020	SELL	$7.8 - $11.52 $97,687 - $144,276	-12,524 Reduced 3.44%	352,020 $3.5 Million
Q1 2020 May 13, 2020	SELL	$5.98 - $13.09 $51,278 - $112,246	-8,575 Reduced 2.3%	364,544 $3.22 Million
Q3 2019 Nov 13, 2019	SELL	$5.88 - $12.35 $66,738 - $140,172	-11,350 Reduced 2.95%	373,119 $2.19 Million
Q2 2019 Aug 07, 2019	SELL	$9.44 - $13.12 $161,046 - $223,827	-17,060 Reduced 4.25%	384,469 $4.61 Million
Q1 2019 May 08, 2019	SELL	$12.07 - $17.54 $239,963 - $348,712	-19,881 Reduced 4.72%	401,529 $4.85 Million
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $396,270 - $569,572	-35,224 Reduced 7.71%	421,410 $5.29 Million
Q3 2018 Nov 13, 2018	BUY	$12.82 - $17.88 $557,823 - $777,994	43,512 Added 10.53%	456,634 $6.78 Million
Q2 2018 Aug 02, 2018	BUY	$16.83 - $21.66 $1.4 Million - $1.8 Million	82,922 Added 25.11%	413,122 $6.95 Million
Q1 2018 May 14, 2018	BUY	$19.24 - $28.03 $4.44 Million - $6.47 Million	230,675 Added 231.78%	330,200 $7.56 Million
Q4 2017 Feb 09, 2018	BUY	$13.96 - $29.05 $1.39 Million - $2.89 Million	99,525	99,525 $2.58 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account